title: The effects of piracetam on cognitive performance in a mouse model of Down's syndrome.
abstract: Piracetam is a nootropic agent that has been shown to improve cognitive performance in a number of animal model systems. Piracetam is reported to be used widely as a means of improving cognitive function in children with Down's syndrome (DS). In order to provide a preclinical assessment of the potential efficacy of piracetam, we examined the effects of a dose range of piracetam in the Ts65Dn mouse model of DS. Ts65Dn mice are trisomic for a region of mouse chromosome 16 with homology to human chromosome 21. Daily piracetam treatment at doses of 0, 75, 150, and 300 mg/kg ip was initiated in 6-week-old male Ts65Dn and euploid control mice. Following 4 weeks of treatment, mice were tested in the visible and hidden-platform components of the Morris water maze and were placed overnight in computerized activity chambers to assess effects on overall activity. Piracetam treatment was continued through the 4 weeks of testing. In control mice, 75 and 150 mg/kg/day piracetam improved performance in both the visible- and hidden-platform tasks. Although low doses of piracetam reduced search time in the visible-platform component in Ts65Dn mice, all piracetam doses prevented trial-related improvements in performance in Ts65Dn mice. The 300-mg/kg/day-piracetam dose was associated with a reversal of the nocturnal spontaneous hyperactivity in Ts65Dn. These data do not provide support for piracetam treatment for individuals with DS.
authors.affiliation: Department of Psychiatry and Behavioral Sciences, Johns Hopkins University School of Medicine, Ross 618, 720 Rutland Avenue, Baltimore, MD 21205-2196, USA. tmoran@jhmi.edu
authors.forename: Timothy H
authors.initials: TH
authors.lastname: Moran
authors.forename: George T
authors.initials: GT
authors.lastname: Capone
authors.forename: Susan
authors.initials: S
authors.lastname: Knipp
authors.forename: Muriel T
authors.initials: MT
authors.lastname: Davisson
authors.forename: Roger H
authors.initials: RH
authors.lastname: Reeves
authors.forename: John D
authors.initials: JD
authors.lastname: Gearhart
mesh_terms: D000818:Animals; D003071:Cognition / Q000187:drug effects*; D003624:Darkness; D004314:Down Syndrome / Q000523:psychology*; D008027:Light; D008297:Male; D018782:Maze Learning / Q000187:drug effects; D051379:Mice; D009043:Motor Activity / Q000187:drug effects; D018697:Nootropic Agents / Q000494:pharmacology*; D010889:Piracetam / Q000494:pharmacology*
chemical_list: D018697:Nootropic Agents; D010889:Piracetam